These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14766265)

  • 1. TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia.
    Kirkpatrick A; Bidwell J; van den Brule AJ; Meijer CJ; Pawade J; Glew S
    Gynecol Oncol; 2004 Feb; 92(2):675-9. PubMed ID: 14766265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
    Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
    J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
    Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
    Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
    van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
    J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
    Chatterjee K; Dandara C; Hoffman M; Williamson AL
    BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
    Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
    Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.
    Ghaderi M; Nikitina L; Peacock CS; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Blackwell JM; Dillner J; Sanjeevi CB
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1067-70. PubMed ID: 11045789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
    Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
    Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion.
    Tavares MC; de Lima Júnior SF; Coelho AV; Marques TR; de Araújo DH; Heráclio Sde A; Amorim MM; de Souza PR; Crovella S
    Ann Hum Biol; 2016 May; 43(3):261-8. PubMed ID: 26079218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.
    Bekkers RL; Bulten J; Wiersma-van Tilburg A; Mravunac M; Schijf CP; Massuger LF; Quint WG; Melchers WJ
    Br J Cancer; 2003 Sep; 89(5):886-90. PubMed ID: 12942122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β -511 is associated with development of cervical carcinoma.
    Dutta S; Chakraborty C; Mandal RK; Basu P; Biswas J; Roychoudhury S; Panda CK
    Cancer Immunol Immunother; 2015 Jul; 64(7):843-51. PubMed ID: 25893807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
    Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
    Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
    Akasofu M; Oda Y
    Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
    Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV infection and microsatellite instability in squamous lesions of the uterine cervix.
    French D; Cermele C; Vecchione A; Cenci M; Vecchione A
    Anticancer Res; 2000; 20(5B):3417-21. PubMed ID: 11131642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
    J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer risk: is there a genetic component?
    Magnusson PK; Gyllensten UB
    Mol Med Today; 2000 Apr; 6(4):145-8. PubMed ID: 10740252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.